Drug Approvals by USFDA in February 2015

Drug 

Date

Indication

Remark

Palbociclib February 4, 2015 Advanced Breast Cancer Accelerated approval
Ranibizumab February 6, 2015 Diabetic Retinopathy (DR) in Diabetic Macular Edema (DME) Expanded approved use
Lenvatinib February 13, 2015  Progressive, Differentiated Thyroid Cancer  
Panobinostat February 23, 2015 Multiple Myeloma First HDAC inhibitor approved to treat Multiple Myeloma
Ceftazidime-avibactam February 25, 2015 Complicated intra-abdominal infections The fifth approved antibacterial drug product designated as a Qualified Infectious Disease Product (QIDP)